UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases New Shares in Clover Health Investments, Corp. (NASDAQ:CLOV)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 435,576 shares of the company's stock, valued at approximately $1,228,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.09% of Clover Health Investments at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Viewpoint Capital Management LLC boosted its stake in Clover Health Investments by 96.8% in the 2nd quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company's stock worth $38,000 after purchasing an additional 15,000 shares in the last quarter. Choreo LLC acquired a new stake in shares of Clover Health Investments during the second quarter worth $344,000. Headlands Technologies LLC purchased a new stake in shares of Clover Health Investments during the second quarter valued at $199,000. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Clover Health Investments by 54.4% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company's stock valued at $42,000 after buying an additional 12,104 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Clover Health Investments in the 2nd quarter valued at $932,000. Hedge funds and other institutional investors own 19.77% of the company's stock.

Clover Health Investments Stock Down 1.9 %

Shares of NASDAQ:CLOV traded down $0.06 during midday trading on Wednesday, reaching $3.15. The company's stock had a trading volume of 7,097,178 shares, compared to its average volume of 7,762,271. The stock has a fifty day moving average of $3.61 and a 200 day moving average of $2.65. Clover Health Investments, Corp. has a twelve month low of $0.61 and a twelve month high of $4.71. The firm has a market capitalization of $1.58 billion, a PE ratio of -15.75 and a beta of 1.94.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.01. The company had revenue of $330.99 million for the quarter, compared to the consensus estimate of $347.60 million. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. During the same period last year, the firm earned ($0.09) EPS. Sell-side analysts anticipate that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CLOV has been the topic of several research analyst reports. Craig Hallum began coverage on Clover Health Investments in a research note on Tuesday. They set a "buy" rating and a $6.00 price target on the stock. UBS Group started coverage on Clover Health Investments in a report on Monday, October 7th. They set a "neutral" rating and a $4.00 target price for the company.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.